Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion
International Immunopharmacology · 2024-09 · 139 · 112707
DOI: 10.1016/j.intimp.2024.112707 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Wei Quan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Telmisartan, Astrocytes, Interleukin-6, Coculture Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Telmisartan, an angiotensin II type 1 receptor (AT1R) blocker, exhibits broad anti-tumor activity. However, in vitro, anti-proliferative effects are shown at doses far beyond the therapeutic plasma concentration. Considering the role of tumor microenvironment in glioma progression, glioma-astrocyte co-cultures were employed to test the anti-tumor potential of low-dose telmisartan. When a high dose was required for a direct anti-proliferative effect on glioma cell lines, a low dose significantly inhibited glioma cell proliferation and migration in the co-culture system. Under co-culture conditions, upregulated IL-6 expression in astrocytes played a critical role in glioma progression. Silencing IL-6 in astrocytes or IL-6R in glioma cells reduced proliferation and migration. Telmisartan (5 μM) inhibited astrocytic IL-6 expression, and its anti-tumor effects were reversed by silencing IL-6 or IL-6R and inhibiting signal transducer and activator of transcription 3 (STAT3) activity in glioma cells. Moreover, the telmisartan-driven IL-6 downregulation was not imitated by losartan, an AT1R blocker with little capacity of peroxisome proliferator-activated receptor-gamma (PPARγ) activation, but was eliminated by a PPARγ antagonist, indicating that the anti-glioma effects of telmisartan rely on its PPARγ agonistic activity rather than AT1R blockade. This study highlights the importance of astrocytic IL-6-mediated paracrine signaling in glioma growth and the potential of telmisartan as an adjuvant therapy for patients with glioma, especially those with hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Physiology, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei, China. Electronic address: wangzf@whu.edu.cn.
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Hubei International Science and Technology Cooperation Base for Research and Clinical Techniques for Brain Glioma Diagnosis and Tre…
Zitieren
APA
Quan, W., Xu, C. S., Ma, C., Chen, X., Yu, D. H., Li, Z. Y., Wang, D. W., Tang, F., Wan, G. P., Wan, J., Wang, Z. F., & Li, Z. Q. (2024). Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion. International Immunopharmacology, 139, 112707. https://doi.org/10.1016/j.intimp.2024.112707
Vancouver
Quan W, Xu CS, Ma C, Chen X, Yu DH, Li ZY, et al. Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion. International Immunopharmacology. 2024;139:112707. doi:10.1016/j.intimp.2024.112707
BibTeX
@article{Quan2024,
author = {Quan, Wei and Xu, Cheng-Shi and Ma, Chao and Chen, Xi and Yu, Dong-Hu and Li, Zhi-Yu and Wang, Dan-Wen and Tang, Feng and Wan, Gui-Ping and Wan, Jing and Wang, Ze-Fen and Li, Zhi-Qiang},
title = {Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion},
journal = {International Immunopharmacology},
year = {2024},
volume = {139},
pages = {112707},
doi = {10.1016/j.intimp.2024.112707}
}
EUVIMED